文献速递心力衰竭与心肌病瓣膜病与结构性心脏病肺血管病与心包/心肌炎

孤立性重度继发性三尖瓣反流中HFpEF的患病率

Prevalence of HFpEF in Isolated Severe Secondary Tricuspid Regurgitation.
PubMed 文献 · JAMA Cardiol · 2025-01-01

该回顾性横断面研究纳入54例无明确病因的重度继发性三尖瓣反流患者,均接受静息与运动右心导管检查。结果显示HFpEF患病率高达74%,但仅35%在导管前被识别;无HFpEF者中71%存在毛细血管前肺动脉高压。指南定义的舒张功能障碍对HFpEF诊断敏感性不足。

要点

  • 重度孤立性继发性三尖瓣反流患者中HFpEF患病率74%,常被漏诊。
  • 无HFpEF者中71%存在毛细血管前肺动脉高压,需鉴别。
  • 指南定义的舒张功能障碍在60%的HFpEF患者中缺失,敏感性不足。

核心结论

  • 重度孤立性继发性三尖瓣反流患者中HFpEF患病率高但常被低估,应积极评估并鉴别毛细血管前肺动脉高压。
  • 基于指南的静息舒张功能障碍标准敏感性不足,左心房功能评估等非侵入性工具可能有助于诊断。

研究设计与样本

  • 回顾性横断面研究,纳入2006年2月至2023年6月在Mayo Clinic接受静息与运动右心导管检查的连续成人患者。
  • 共54例重度孤立性继发性三尖瓣反流患者,平均年龄70.8岁,女性34例(63%)。
  • 排除左室射血分数<50%、血流动力学显著的左侧瓣膜病、先天性心脏病、浸润性或肥厚型心肌病、心包疾病或既往心脏手术者。

主要发现

  • HFpEF在40例(74%)患者中被识别,但仅19例(35%)在右心导管前被认识。
  • 剩余14例无HFpEF患者中,10例(71%)诊断为毛细血管前肺动脉高压。
  • 24例(60%)随后诊断为HFpEF的患者缺乏指南定义的舒张功能障碍。
  • 左心房排空分数AUC=0.90(95%CI 0.82-0.98),左心房应变AUC=0.91(95%CI 0.83-0.99),对HFpEF有良好判别能力。

关键数值与推荐

  • 舒张功能障碍定义为4项舒张参数中至少3项异常或3项中至少2项异常(内侧e'、内侧E/e'、三尖瓣反流速度、左心房容积指数)。
  • HFpEF诊断标准:静息肺动脉楔压≥15 mm Hg,或抬腿时≥19 mm Hg,或运动时≥25 mm Hg。

临床怎么用

  • 对重度孤立性继发性三尖瓣反流患者应严格评估HFpEF和毛细血管前肺动脉高压,因两者管理需求不同。
  • 不应仅依赖指南定义的静息舒张功能障碍标准排除HFpEF,可考虑左心房功能评估等非侵入性工具。

局限性

  • 回顾性横断面设计,样本量较小(54例),来自单中心。
  • 转诊行右心导管检查的选择偏倚可能影响患病率估计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Secondary tricuspid regurgitation (STR) is observed in multiple cardiac and pulmonary diseases. Heart failure with preserved ejection fraction (HFpEF) is a common cause of STR that may be overlooked, along with precapillary etiologies of pulmonary hypertension (PH). OBJECTIVES: To investigate the prevalence of HFpEF and precapillary PH in patients with severe STR of undefined etiology (isolated STR) referred for exercise right heart catheterization (RHC), and to evaluate the performance of noninvasive measures to identify HFpEF. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cross-sectional study included consecutive adults with severe STR in the absence of EF less than 50%, hemodynamically significant left-sided valve disease, congenital heart disease, infiltrative or hypertrophic cardiomyopathy, pericardial disease, or prior cardiac procedures who underwent rest-and-exercise RHC between February 2006 and June 2023 at Mayo Clinic and transthoracic echocardiography less than 90 days prior. Diastolic dysfunction (DD) was defined by at least 3 of 4 or 2 of 3 abnormal diastolic parameters (medial e', medial E/e', tricuspid regurgitation [TR] velocity, left atrial volume index). HFpEF was diagnosed when pulmonary arterial wedge pressure was at least 15 mm Hg at rest, at least 19 mm Hg with feet up, or at least 25 mm Hg during exercise. Data analysis was performed from November 2023 to March 2024. MAIN OUTCOMES AND MEASURES: The prevalence of HFpEF and precapillary PH in severe isolated STR was determined, and performance of noninvasive measures to identify HFpEF was evaluated. RESULTS: Overall, 54 patients with severe isolated STR (mean [SD] age, 70.8 [12.5] years; 34 [63%] female) were identified. The primary indication for RHC was evaluation of TR prior to potential intervention in 36 patients (67%), evaluation of PH in 13 (24%), and confirmation of HFpEF in 5 (9%). HFpEF was identified in 40 patients (74%) but was recognized prior to RHC in only 19 patients (35%). Of the 14 remaining patients without HFpEF, precapillary PH was diagnosed in 10 (71%). Guideline-defined DD was absent in 24 patients (60%) who were subsequently diagnosed with HFpEF. Left atrial emptying fraction (area under the receiver operating characteristic curve [AUC] = 0.90; 95% CI, 0.82-0.98) and strain (AUC = 0.91; 95% CI, 0.83-0.99) had robust discrimination for HFpEF. CONCLUSIONS AND RELEVANCE: The findings suggest that HFpEF is underdiagnosed and should be rigorously evaluated for in patients with severe isolated STR, along with precapillary PH, as both have distinct requirements for management. Resting DD based on current guidelines is insufficiently sensitive in these patients, indicating a pressing need for other noninvasive diagnostic tools, such as left atrial function assessment.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Naser JA, Harada T, Reddy YN, et al. Prevalence of HFpEF in Isolated Severe Secondary Tricuspid Regurgitation. JAMA Cardiol. 2025. PMID: 39504003. doi:10.1001/jamacardio.2024.3767

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。